Cases & Deals

  • Home
  • Practices
  • ConjuChem develops patent portfolio and participates in inter partes reexamination proceeding relating to therapeutic peptide conjugates

Share

ConjuChem develops patent portfolio and participates in inter partes reexamination proceeding relating to therapeutic peptide conjugates

February 2008

Client(s) ConjuChem Biotechnologies, Inc.

On behalf of ConjuChem Biotechnologies, Inc., Jones Day assisted with patent prosecution strategy and portfolio development relating to therapeutic peptide conjugates with prolonged half-lives. This work includes counseling and handling of an inter partes reexamination proceeding.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.